BRIEF published on 10/17/2024 at 06:50, 1 month 4 days ago ABB Reports Q3 2024 Financial Performance Revenues Financial Results Operational EBITA Order Growth ABB Q3 2024
PRESS RELEASE published on 10/17/2024 at 06:45, 1 month 4 days ago Q3 2024 results ABB Ltd reports positive Q3 2024 results with order growth, record margin, and strong performance despite revenue challenges. CEO Morten Wierod optimistic about long-term prospects ABB Ltd Order Growth Q3 2024 Results Record Margin CEO Morten Wierod
BRIEF published on 07/18/2024 at 06:50, 4 months 3 days ago ABB Reports Solid Demand and Record-High Operational EBITA Margin Financial Results Sustainability 2024 Operational EBITA ABB
PRESS RELEASE published on 07/18/2024 at 06:45, 4 months 3 days ago Solid demand; record-high Operational EBITA margin ABB Ltd reports solid demand in Q2 2024 with record-high Operational EBITA margin of 19%. Orders at $8,435 million, revenues at $8,239 million. CEO Björn Rosengren pleased with results Financial Results ABB Ltd Operational EBITA Q2 2024 Record-high
BRIEF published on 04/18/2024 at 06:50, 7 months 3 days ago ABB Ltd Announces Q1 2024 Financial Results ABB Ltd Operational EBITA Leadership Change Q1 2024 Financial Results Cash Flow Increase
PRESS RELEASE published on 04/18/2024 at 06:45, 7 months 3 days ago Q1 2024 results ABB Ltd reports Q1 2024 results with positive book-to-bill, record-high margin, and strong cash flow. CEO is confident for 2024 with improved performance across business areas Cash Flow ABB Ltd Q1 2024 Results Margin Book-to-bill
PRESS RELEASE published on 02/23/2024 at 07:00, 8 months 27 days ago Notice of ABB’s Annual General Meeting on March 21, 2024 ABB announces Annual General Meeting on March 21, 2024, including registration details. Shareholders can participate in-person or via proxy. Meeting agenda covers key corporate matters Annual General Meeting Shareholders ABB Proxy Corporate Matters
BRIEF published on 02/23/2024 at 07:00, 8 months 27 days ago Notice of ABB's Annual General Meeting on March 21, 2024 Automation Electrification Sustainability Report ABB AGM 2024 E-voting
PRESS RELEASE published on 02/23/2024 at 06:45, 8 months 27 days ago ABB publishes 2023 Integrated Report ABB publishes 2023 Integrated Report detailing strategy, financial and sustainability performance. Achieved 76% reduction in GHG emissions. CEO Rosengren highlights record year for ABB Record Year ABB GHG Emissions Integrated Report Sustainability Targets
BRIEF published on 02/23/2024 at 06:45, 8 months 27 days ago ABB Releases its 2023 Integrated Report Highlighting Significant Progress in Sustainable Development Sustainable Development Energy Transition ABB GHG Emissions Integrated Report
Published on 11/21/2024 at 13:30, 34 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 34 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 4 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 4 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 4 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 29 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 49 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 6 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 44 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 19 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 19 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
